Informa PLC Completion of Pharma Intelligence divestment (4796N)
June 01 2022 - 7:15AM
UK Regulatory
TIDMINF
RNS Number : 4796N
Informa PLC
01 June 2022
Informa PLC Press Release
1 June 2022
Completion of GBP1.9bn Pharma Intelligence agreement
Portfolio re-balancing and accelerating shareholder returns
Informa (LSE: INF.L), the international Academic Markets, B2B
Markets and Digital Services Group today confirmed the completion
of its GBP1.9bn Pharma Intelligence agreement which forms part of
the 2021-2024 Growth Acceleration Plan II ("GAP II").
The agreement announced on 10 February sees the Group receive
c.GBP1.7bn in cash before tax deductions and a c.15% shareholding
in the ongoing business. This c.15% equity interest ranks pari
passu with Warburg Pincus' equity (the acquirer), enabling Informa
to realise significant value today, whilst sharing in the future
value created from further growth and portfolio expansion.
Re-balancing the Group's portfolio is a key part of Informa's
GAP II programme, a four-year plan designed to create a more
focused, higher growth business, with digital and data excellence
at its core. Following Pharma Intelligence, the Group is now
reviewing its Financial Intelligence portfolio.
The Group will provide an update on GAP II Shareholder Returns
within its AGM Trading Update on 16 June 2022. Since March, the
Group has completed c.GBP257m of its current GBP300m share buyback
commitment, at a weighted average price of 581p, leading to the
cancellation of c.44m shares.
Enquiries
Stephen A. Carter, Chief Executive +44 (0) 20 8052 0400
Gareth Wright, Finance Director +44 (0) 20 8052 0400
Richard Menzies-Gow, Director of IR
& Communications +44 (0) 20 8052 2787
Tim Burt / Simon Duke - Teneo +44 (0) 20 7240 2486
------------------------------------ --------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DISBFLLXLELBBBF
(END) Dow Jones Newswires
June 01, 2022 07:15 ET (11:15 GMT)
Informa (LSE:INF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Informa (LSE:INF)
Historical Stock Chart
From Aug 2023 to Aug 2024